Literature DB >> 20589844

Mechanism of antibody reduction in cell culture production processes.

Yung-Hsiang Kao1, Daniel P Hewitt, Melody Trexler-Schmidt, Michael W Laird.   

Abstract

We recently observed a significant disulfide reduction problem during the scale-up of a manufacturing process for a therapeutic antibody using a CHO expression system. Under certain conditions, extensive reduction of inter-chain disulfide bonds of an antibody produced by CHO cell culture may occur during the harvest operations and/or the protein A chromatography step, resulting in the observation of antibody fragments (light chain, heavy chain, and various combination of both) in the protein A pools. Although all conditions leading to disulfide reduction have not been completely identified, an excessive amount of mechanical cell lysis generated at the harvest step appears to be an important requirement for antibody reduction (Trexler-Schmidt et al., 2010). We have been able to determine the mechanism by which the antibody is reduced despite the fact that not all requirements for antibody reduction were identified. Here we present data strongly suggesting that the antibody reduction was caused by a thioredoxin system or other reducing enzymes with thioredoxin-like activity. The intracellular reducing enzymes and their substrates/cofactors apparently were released into the harvest cell culture fluid (HCCF) when cells were exposed to mechanical cell shear during harvest operations. Surprisingly, the reducing activity in the HCCF can last for a long period of time, causing the reduction of inter-chain disulfide bonds in an antibody. Our findings provide a basis for designing methods to prevent the antibody reduction during the manufacturing process.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589844     DOI: 10.1002/bit.22848

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  18 in total

1.  Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.

Authors:  Katariina M Hutterer; Robert W Hong; Jonathon Lull; Xiaoyang Zhao; Tian Wang; Rex Pei; M Eleanor Le; Oleg Borisov; Rob Piper; Yaoqing Diana Liu; Krista Petty; Izydor Apostol; Gregory C Flynn
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

2.  The potential of hydrodynamic damage to animal cells of industrial relevance: current understanding.

Authors:  Weiwei Hu; Claudia Berdugo; Jeffrey J Chalmers
Journal:  Cytotechnology       Date:  2011-07-22       Impact factor: 2.058

Review 3.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

4.  Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.

Authors:  Cheng Du; Yunping Huang; Ameya Borwankar; Zhijun Tan; Anthony Cura; Joon Chong Yee; Nripen Singh; Richard Ludwig; Michael Borys; Sanchayita Ghose; Nesredin Mussa; Zheng Jian Li
Journal:  MAbs       Date:  2018-01-23       Impact factor: 5.857

5.  Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics.

Authors:  Amit Kumar; Deniz Baycin-Hizal; Daniel Wolozny; Lasse Ebdrup Pedersen; Nathan E Lewis; Kelley Heffner; Raghothama Chaerkady; Robert N Cole; Joseph Shiloach; Hui Zhang; Michael A Bowen; Michael J Betenbaugh
Journal:  J Proteome Res       Date:  2015-10-13       Impact factor: 4.466

6.  Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations.

Authors:  Brian Mullan; Bryan Dravis; Amareth Lim; Ambrose Clarke; Susan Janes; Pete Lambooy; Don Olson; Tomas O'Riordan; Bruce Ricart; Alexander G Tulloch
Journal:  BMC Proc       Date:  2011-11-22

7.  A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies.

Authors:  Nabila Aboulaich; Wai Keen Chung; Jenny Heidbrink Thompson; Christopher Larkin; David Robbins; Min Zhu
Journal:  Biotechnol Prog       Date:  2014-07-26

Review 8.  The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.

Authors:  Daniel G Bracewell; Richard Francis; C Mark Smales
Journal:  Biotechnol Bioeng       Date:  2015-07-14       Impact factor: 4.530

9.  Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest.

Authors:  Gayle E Derfus; Jemelle Dizon-Maspat; Jared T Broddrick; Arleene C Velayo; Josh D Toschi; Rodell T Santuray; Stephen K Hsu; Charles M Winter; Rajesh Krishnan; Ashraf Amanullah
Journal:  MAbs       Date:  2014-02-19       Impact factor: 5.857

10.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.